source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

Metrion Biosciences and AMRI collaborate on ion channel drug discovery services

Metrion Biosciences logo 2.3.18AMRI logo 23.10.18

Ion channel CRO and drug discovery specialist Metrion Biosciences Limited and a global contract research, development and manufacturing organisation AMRI have signed a new collaboration agreement that will promote Metrion’s electrophysiology and ion channel screening expertise to global pharmaceutical and biotechnology clients.

As part of the agreement, AMRI will be able to offer its customers access to Metrion’s broad portfolio of assay tools and technologies for ion channel screening, cardiac safety profiling and neuroscience applications. Metrion’s customers will benefit in turn from ready access to AMRI’s suite of integrated drug discovery solutions, including expertise in medicinal chemistry, high-content imaging, cell-based assays, high-throughput screening and screening by mass spectrometry.

For further information about Metrion Biosciences visit and for further information about AMRI visit

Last modified onWednesday, 24 October 2018 07:13

Related items

Latest from Tom Mulligan